US Broker Ratings

Janux Therapeutics, Inc. (JANX): Investor Outlook with a Promising 113% Upside Potential

Janux Therapeutics, Inc. (NASDAQ: JANX) is drawing considerable attention in the biotechnology sector, not just due to its innovative approach to cancer treatment but also because..

Artivion, Inc. (AORT) Stock Analysis: Exploring a 78% Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a notable player in the healthcare sector’s medical devices industry, has caught the attention of investors with its compelling growth potential. Headquartered..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 62% Upside Potential

Privia Health Group, Inc. (PRVA), a prominent player in the healthcare sector, is gaining attention from investors due to its potential for significant upside. Currently trading..

Mesoblast Limited (MESO) Stock Analysis: A Deep Dive into its 139% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, stands at the forefront of regenerative medicine with its proprietary technology platform centered around mesenchymal lineage cells. As..

Celldex Therapeutics (CLDX) Stock Analysis: A Biotech with a 55.9% Potential Upside and 14 Buy Ratings

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company renowned for developing therapeutic antibodies, is making waves in the biotechnology sector. With a market capitalization of $2.98..

AdaptHealth Corp. (AHCO) Stock Analysis: Can a 56% Upside Offset Current Challenges?

AdaptHealth Corp. (NASDAQ: AHCO) appears to be a company worth watching closely, especially given the potential 56.52% upside as suggested by analyst target prices. This intriguing..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 117% Upside Potential in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) is capturing significant attention in the biotechnology sector, with a market cap of $3.2 billion and an enticing potential upside of..

Novavax, Inc. (NVAX) Stock Analysis: Navigating a Potential 34.51% Upside Amidst Volatility

Novavax, Inc. (NASDAQ: NVAX), a key player in the biotechnology sector, is capturing investor attention with a potential upside of 34.51%. This potential, combined with its..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Uncharted Waters with a 22% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands as a pivotal player in the rapidly evolving healthcare sector, specifically within the health information services industry. With a market..

NovoCure Limited (NVCR) Stock Analysis: Unpacking the 64% Potential Upside in the Medical Device Sector

Investors interested in the intersection of cutting-edge technology and healthcare might find NovoCure Limited (NASDAQ: NVCR) an intriguing prospect. Specializing in innovative oncology solutions, this Swiss-based..

Indivior Pharmaceuticals (INDV) Stock Analysis: Exploring a 37.91% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has become a compelling prospect for investors seeking exposure in the healthcare sector, particularly within the niche of drug manufacturers specializing..

Azenta, Inc. (AZTA) Investor Outlook: Analyzing Growth Potential Amidst a 4.44% Upside

Azenta, Inc. (NASDAQ: AZTA), a key player in the Healthcare sector under the Medical Instruments & Supplies industry, presents intriguing opportunities for investors with its innovative..

Neogen Corporation (NEOG) Stock Analysis: What Investors Need to Know About Its Market Position and Growth Potential

Neogen Corporation (NASDAQ: NEOG), with its focus on food and animal safety, stands as a notable player in the healthcare sector, particularly within the medical devices..

Progyny, Inc. (PGNY) Investor Outlook: Evaluating the 28% Upside Potential

Progyny, Inc. (NASDAQ: PGNY) presents a compelling opportunity for investors keen on the healthcare sector, particularly within the growing niche of fertility and family health benefits..

National HealthCare Corporation (NHC) Stock Analysis: Stability and Growth in Healthcare Facility Operations

National HealthCare Corporation (NYSE: NHC) is a prominent player in the healthcare sector, specializing in the management and operation of a wide range of medical care..

Liquidia Corporation (LQDA): Investor Outlook Highlights 62.20% Potential Upside Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biopharmaceutical industry, has captured the attention of investors with its innovative approach to treating rare cardiopulmonary diseases...

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 50.89% Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, is currently capturing investor attention with its significant growth potential. With a market capitalization of..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 40% Potential Upside in Healthcare Facilities

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of individual investors with..

LivaNova PLC (LIVN) Stock Analysis: A Healthcare Innovator with a 13.98% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a leading player in the healthcare sector’s medical devices industry, offers investors a compelling growth story underpinned by its innovative product offerings..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices sector, is making waves with its innovative solutions for diabetes management. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds